Monitoring and Evaluation Study of Project ECHO for ILD

Interstitial Lung Diseases Clinical Trial

Official title:

Monitoring and Evaluation Study of Project ECHO for ILD

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05455437
• Other study ID #: ILDC-002
• Status: Enrolling by invitation
• Start date: July 2022
• Est. completion date: March 2024

Study information

• Verified date: July 2022
• Source: Pulmonary Care and Research Collaborative Limited
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The study will utilize pre-post survey measures to evaluate Project ECHO for ILD with respect to an initial set of practice and clinical outcomes and relies on questionnaire data obtained from providers participating in Project ECHO for ILD at baseline, at 6 months, and at study end.

Description:

Project ECHO (Extension for Community Healthcare Outcomes) is a knowledge-sharing model to expand the capacity of the health care workforce so that more people can get high quality care for their health conditions in or near the communities where they live. The model brings specialty disease expertise to community providers through its hub-and-spoke networks. The model relies on videoconferencing to connect local providers in non-urban or underserved communities (spoke sites) with an interdisciplinary team of specialist providers at academic medical centers (hubs) during virtual "teleECHO" clinic sessions, which include brief educational lectures and case-based, experiential learning. It is a guided, technology-enabled collaborative practice model in which community providers become experts in an area of community need within the scope of their practice, operating with increasing independence as their skills and self-efficacy grow. The model establishes meaningful, ongoing relationships with hub specialists who serve as telementors for spoke providers and relies on case-based learning from presentations of real-world de-identified patient cases. The overarching goal of the project is to implement and evaluate an adaptation of the ECHO model to interstitial lung disease (ILD) diagnosis and care among primary care physicians (PCPs) and community pulmonologists in non-urban or underserved communities.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 200
• Est. completion date: March 2024
• Est. primary completion date: December 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Pulmonologists and primary care physicians who participate in Project ECHO for ILD. Exclusion Criteria: -

Related Conditions & MeSH terms

• Interstitial Lung Diseases
• Lung Diseases
• Lung Diseases, Interstitial

Locations

Country	Name	City	State
United States	Pulmonary Care and Research Collaborative, Ltd.	Boston	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Pulmonary Care and Research Collaborative Limited	Genentech, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Impact on procedural knowledge	Change in participants' skills or competence in knowing ILD testing and treatment procedures based on a Likert scale rating (1=no skill and 7=expert, teach other) included in the structured participant surveys administered at baseline, 6 months, and at study end.	Up to 18 months
Primary	Impact on local care utilization	Change of proportion of patients utilizing local ILD care services, including the frequency of local follow-up visits and testing. Change in scores will be calculated between structured participant surveys responses at baseline, 6 months, and at study end.	Up to 18 months
Secondary	Time to ILD diagnosis	The amount of time it takes for a participant's patient to be given an established, named ILD diagnosis (IPAF, IPF, HP, CTD-ILD, myositis-ILD, idiopathic NSIP, etc.) from onset of respiratory symptoms and from the time of first pulmonologist appointment. This data will be obtained from teleECHO clinic management records and participants' case and follow-up reporting for patients who were presented to the ECHO for diagnosis.	Up to 18 months
Secondary	Content expert facilitation	Proportion of participants who agree that the quality of content expert facilitation was adequate during the teleECHO session. This will be collected monthly from post-session surveys via a Likert scale (1=strongly disagree and 5=strongly agree).	Up to 18 months